Reuters logo
BRIEF-Cantargia gains approval to initiate the canfour clinical trial
July 21, 2017 / 7:51 AM / 2 months ago

BRIEF-Cantargia gains approval to initiate the canfour clinical trial

July 21 (Reuters) - CANTARGIA AB:

* CANTARGIA GAINS APPROVAL TO INITIATE THE CANFOUR CLINICAL TRIAL OF IMMUNO-ONCOLOGY PRODUCT CANDIDATE CAN04

* APPROVED BY REGULATORY AUTHORITIES AS WELL AS ETHICS COMMITTEES IN DENMARK AND NORWAY WITH REVIEW IS ONGOING IN ADDITIONAL COUNTRIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below